Cipla can give high returns in long term: ValueQuest
ValueQuest CIO Ravi Dharamshi says Cipla will do well as it
is entering regulated markets like the US and Europe. He says investment in
select pharma firms continues to make sense despite a run-up in valuations.
Other Experts Videos
